{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:15:24Z","timestamp":1774502124516,"version":"3.50.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:00:00Z","timestamp":1384473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080885","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T18:02:45Z","timestamp":1384538565000},"page":"e80885","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Xiaohong","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3816\/CLC.2003.n.021","article-title":"The potential contributions of chronic inflammation to lung carcinogenesis","volume":"5","author":"S Ballaz","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"F Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"TJ Bayliss","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1101\/gad.1549407","article-title":"Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis","volume":"21","author":"B Ancrile","year":"2007","journal-title":"Genes Dev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"d340","DOI":"10.2741\/A136","article-title":"Molecular and cellular biology of interleukin-6 and its receptor","volume":"1","author":"ET Keller","year":"1996","journal-title":"Front Biosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00432-012-1314-z","article-title":"A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk","volume":"139","author":"J Chen","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-008-9212-z","article-title":"Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis","volume":"20","author":"K Heikkil\u00e4","year":"2009","journal-title":"Cancer Causes Control"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12032-012-0414-6","article-title":"Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer","volume":"30","author":"L Bai","year":"2013","journal-title":"Med Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5301\/JBM.2008.172","article-title":"Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer","volume":"17","author":"GE Carpagnano","year":"2002","journal-title":"Int J Biol Markers"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bjc.1995.212","article-title":"Serum levels of interleukin 6 in patients with lung cancer","volume":"71","author":"H Yanagawa","year":"1995","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/sj.onc.1209464","article-title":"Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion","volume":"25","author":"HH Yeh","year":"2006","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1992.tb03063.x","article-title":"IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2","volume":"88","author":"H Yanagawa","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejcts.2007.01.027","article-title":"Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery","volume":"31","author":"TJ Szczesny","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5761\/atcs.oa.10.01627","article-title":"Does postoperative serum interleukin-6 influence early recurrence after curative pulmonary resection of lung cancer?","volume":"17","author":"H Kita","year":"2011","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/030089160409000207","article-title":"Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer","volume":"90","author":"N Song\u00fcr","year":"2004","journal-title":"Tumori"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/ijc.27892","article-title":"Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy","volume":"132","author":"CH Chang","year":"2013","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1066896911436274","article-title":"Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer","volume":"20","author":"E Koh","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"ref18","first-page":"3251","article-title":"Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer","volume":"32","author":"H Ujiie","year":"2012","journal-title":"Anticancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1055-9965.EPI-08-0705","article-title":"Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians","volume":"18","author":"L Enewold","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1385\/MO:22:4:353","article-title":"Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer","volume":"22","author":"F Tas","year":"2005","journal-title":"Med Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1998.0398","article-title":"Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer","volume":"11","author":"F Mart\u00edn","year":"1999","journal-title":"Cytokine"},{"key":"ref22","first-page":"139","article-title":"Prognostic value of serial serum interleukin-6 level estimation in patients with lung cancer: a preliminary report","volume":"70","author":"A Wojciechowska-Lacka","year":"1997","journal-title":"Yale J Biol Med"},{"key":"ref23","first-page":"1773","article-title":"IL-6 and VEGF in small cell lung cancer patients","volume":"30","author":"E W\u00f3jcik","year":"2010","journal-title":"Anticancer Res"},{"key":"ref24","first-page":"649","article-title":"Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer","volume":"5","author":"F De Vita","year":"1998","journal-title":"Oncol Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2169\/internalmedicine.35.212","article-title":"Lung cancer producing interleukin-6","volume":"35","author":"E Takeuchi","year":"1996","journal-title":"Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00262-004-0533-9","article-title":"Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer","volume":"53","author":"H Yamaji","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"ref27","first-page":"310","article-title":"Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells","volume":"41","author":"H Yi","year":"2012","journal-title":"Int J Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e3077","DOI":"10.1371\/journal.pone.0003077","article-title":"Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties","volume":"3","author":"V Levina","year":"2008","journal-title":"PLOS ONE"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.lungcan.2011.07.001","article-title":"Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6\/JAK2\/STAT3 pathway","volume":"75","author":"HS Hsu","year":"2012","journal-title":"Lung Cancer"},{"key":"ref30","first-page":"177","article-title":"Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies","volume":"3","author":"K Tawara","year":"2011","journal-title":"Cancer Manag Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e37960","DOI":"10.1371\/journal.pone.0037960","article-title":"Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway","volume":"7","author":"CL Yang","year":"2012","journal-title":"PLOS ONE"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1940-6207.CAPR-10-0180","article-title":"Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis. Cancer","volume":"4","author":"CE Ochoa","year":"2011","journal-title":"Prev Res (Phila)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/1535-7163.MCT-10-0502","article-title":"JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling","volume":"10","author":"L Song","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1158\/1535-7163.MCT-12-0311","article-title":"Activation of IL-6R\/JAK1\/STAT3 signaling induces De Novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation","volume":"11","author":"SM Kim","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.1009472107","article-title":"TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer","volume":"107","author":"Z Yao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"RS Herbst","year":"2008","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","article-title":"LKB1 modulates lung cancer differentiation and metastasis","volume":"448","author":"H Ji","year":"2007","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"M Kopf","year":"1994","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"EL Jackson","year":"2001","journal-title":"Genes Dev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"J Jonkers","year":"2001","journal-title":"Nat Genet"},{"key":"ref41","first-page":"787","article-title":"The role of tumor-associated macrophage in tumor progression","volume":"4","author":"K Fukuda","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"LM Coussens","year":"2002","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/carcin\/bgp198","article-title":"ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis","volume":"30","author":"KM O'Hayer","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"&quot;Re-educating&quot; tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"T Hagemann","year":"2008","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08462","article-title":"Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma","volume":"462","author":"E Meylan","year":"2009","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.08.040","article-title":"Wnt signaling in lung cancer","volume":"222","author":"J Mazieres","year":"2005","journal-title":"Cancer Lett"},{"key":"ref47","first-page":"131","article-title":"Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation","volume":"20","author":"M Suganuma","year":"2002","journal-title":"Int J Oncol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","article-title":"Tumor necrosis factor or tumor promoting factor?","volume":"13","author":"F Balkwill","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#","article-title":"Detection and localization of Mip-3alpha\/LARC\/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer","volume":"81","author":"J Kleeff","year":"1999","journal-title":"Int J Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1021\/bi035895h","article-title":"Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta)","volume":"43","author":"TR Ott","year":"2004","journal-title":"Biochemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.semcancer.2012.02.010","article-title":"Tumor associated regulatory dendritic cells","volume":"22","author":"Y Ma","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"ref52","first-page":"690571","article-title":"T cells in gastric cancer: friends or foes","author":"A Amedei","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-5002(03)00225-3","article-title":"Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)","volume":"41","author":"T Mukohara","year":"2003","journal-title":"Lung Cancer"},{"key":"ref54","first-page":"931","article-title":"STAT3 and MAPK in human lung cancer tissues and suppression of oncogenic growth by JAB and dominant negative STAT3","volume":"24","author":"Y Seki","year":"2004","journal-title":"Int J Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/embor.2009.243","article-title":"IKK\/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis","volume":"10","author":"J Bollrath","year":"2009","journal-title":"EMBO Rep"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:34:38Z","timestamp":1588962878000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080885"}},"subtitle":[],"editor":[{"given":"Victoria","family":"Lawson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080885","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}